302 filings
Page 4 of 16
8-K
81ojxki7es7 908y
7 Nov 22
TRxADE HEALTH Reports Third Quarter Gross Margin of 58% and Q3 2022 Financial Results
4:31pm
PRE 14A
fi44c
24 Oct 22
Preliminary proxy
5:29pm
8-K
jwe4w0boo9hbf3z hh16
19 Oct 22
Other Events
8:30am
8-K
i28qk
14 Oct 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:30am
8-K
nn6h4rl450 qw
7 Oct 22
TRxADE Health Announces Pricing of $1.8 Million Registered Direct Offering
4:50pm
424B5
srvualt l0l
6 Oct 22
Prospectus supplement for primary offering
5:28pm
8-K
1obtwxe0yxwdgp gf9j
3 Oct 22
Departure of Directors or Certain Officers
9:15am
8-K
timz1bd2zfpp5l7w2
27 Sep 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:10pm
8-K
lj42x3f8jndwcm7w2u
13 Sep 22
Entry into a Material Definitive Agreement
4:30pm
8-K
s7tswt0o e141
1 Sep 22
Departure of Directors or Certain Officers
4:30pm
424B5
3cx1l0pdd ey
23 Aug 22
Prospectus supplement for primary offering
4:01pm
EFFECT
iom43ptbzeqi1dic
9 Aug 22
Notice of effectiveness
12:15am
UPLOAD
p9wyjkrzoxr55ipeph5
4 Aug 22
Letter from SEC
12:00am
CORRESP
7l7o88xuhh 962kxww
4 Aug 22
Correspondence with SEC
12:00am
8-K
uz13zf9do
1 Aug 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K/A
d76i6r twn
26 Jul 22
Correction Notice to TRxADE HEALTH Press Release Reporting Second Quarter Revenue Growth of 73% and Q2 2022 Financial Results
7:30am
8-K
67zxje6lir0 x8t
25 Jul 22
TRxADE HEALTH Reports Second Quarter Revenue Growth of 73% and Q2 2022 Financial Results
4:30pm